COVID vaccine for kids: Approval granted to COVID vaccine Corbevax for children between 12-18 years; here

India's first indigenously developed protein sub-unit COVID-19 Vaccine Corbevax is India’s first indigenously developed protein sub-unit COVID-19 vaccine. The vaccine has been developed by Biological E. Limited in collaboration with Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD) and Baylor College of Medicine (Baylor) in Houston, Texas. 'CORBEVAX is a “recombinant protein sub-unit” vaccine, developed from a component of the spike protein on the virus’s surface, which helps the body build the immune response against the virus. The vaccine has the Receptor Binding Domain (RBD) protein as an antigen, and also an optimum adjuvant consisting of Dynavax (DVAX) CpG 1018 and alum,' Biological E Limited has said.